Form 424B2 - Prospectus [Rule 424(b)(2)]
December 06 2024 - 4:09PM
Edgar (US Regulatory)
Supplement dated December 6, 2024
to Pricing Supplement dated October 24, 2024,
Product Supplement EQUITY ARN-1 dated September 5, 2023,
Prospectus Supplement dated September 5, 2023 and Prospectus dated
September 5, 2023
(together, the “Note Prospectus”)
|
|
Filed pursuant to Rule 424(b)(2)
Registration Statement No. 333-272447
|
Canadian Imperial Bank of Commerce
Accelerated Return Notes® Linked
to
the S&P 500® Index due on
January 30, 2026
CUSIP: 13608R281 (the “notes”)
This document (the “supplement”) supplements the Note Prospectus
in connection with any secondary market transactions in the notes by us, the agent or any of our respective affiliates. Certain terms
used but not defined in this supplement have the meanings set forth in the Note Prospectus.
The Starting Value for the notes was defined in the final pricing supplement
dated October 24, 2024 (the “Final Pricing Supplement”) as the lowest closing level of the Market Measure on any Market Measure
Business Day (subject to adjustment as set forth in the Final Pricing Supplement) during the Starting Value Determination Period. The
closing level of the Market Measure on October 24, 2024, the first day of the Starting Value Determination Period, was 5,809.86.
The Starting Value Determination Period expired on November 25, 2024.
The lowest closing level of the Market Measure on any Market Measure Business Day during the Starting Value Determination Period was 5,705.45,
which was the closing level of the Market Measure on October 31, 2024.
Therefore, the Starting Value for the notes is 5,705.45.
Documentation
You should read this supplement, together with the documents listed
below, which together contain the terms of the notes and supersede all prior or contemporaneous oral statements as well as any other written
materials. You should carefully consider, among other things, the matters set forth in “Risk Factors” beginning on page TS-6
of the Final Pricing Supplement, page PS-6 of the product supplement, page S-1 of the prospectus supplement and page 1
of the prospectus, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment,
legal, tax, accounting, and other advisors before you invest in the notes.
You may access these documents on the Securities and Exchange Commission
(“SEC”) website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date
on the SEC website):
| · | Final
Pricing Supplement dated October 24, 2024: |
https://www.sec.gov/Archives/edgar/data/1045520/000110465924111830/tm2425297d37_424b2.htm
| · | Product Supplement EQUITY ARN-1 dated September 5, 2023: |
https://www.sec.gov/Archives/edgar/data/1045520/000110465923098258/tm2325339d3_424b5.htm
| · | Prospectus supplement dated September 5, 2023: |
https://www.sec.gov/Archives/edgar/data/1045520/000110465923098166/tm2322483d94_424b5.htm
| · | Prospectus dated September 5, 2023: |
https://www.sec.gov/Archives/edgar/data/1045520/000110465923098163/tm2325339d10_424b3.htm
Our Central Index Key, or CIK, on the SEC website is 1045520. Unless
otherwise indicated or unless the context requires otherwise, all references in this supplement to “we,” “us,”
“our,” or similar references are to Canadian Imperial Bank of Commerce.
Canadian Imperial Bank o... (NYSE:CM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Canadian Imperial Bank o... (NYSE:CM)
Historical Stock Chart
From Dec 2023 to Dec 2024